CN Patent

CN101679308B — Hedgehog途径抑制剂

Assigned to Exelixis Inc · Expires 2014-05-07 · 12y expired

What this patent protects

本发明涉及式(I)化合物或其单一异构体；其中所述化合物任选作为药学上可接受的盐、水合物、溶剂合物或其组合，此外，涉及制备式I化合物的方法，以及使用式(I)化合物治疗癌症的方法。

USPTO Abstract

本发明涉及式(I)化合物或其单一异构体；其中所述化合物任选作为药学上可接受的盐、水合物、溶剂合物或其组合，此外，涉及制备式I化合物的方法，以及使用式(I)化合物治疗癌症的方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN101679308B
Jurisdiction
CN
Classification
—
Expires
2014-05-07
Drug substance claim
No
Drug product claim
No
Assignee
Exelixis Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.